Paul Littman, DO
Obstetrics & Gynecology · Hackettstown, NJNPI 1538364369
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (53.6%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 26 manufacturers reported payments, led by Caldera Medical, Inc at 57.4% of the total. Reporting peaked in 2021 at $3,304 and has fallen 85.7% since, to $473 in 2025. Among obstetrics & gynecology clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 138 payments — averaging $98.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Caldera Medical, Inc$8K
- Axonics, Inc.$3K
- Astellas Pharma US Inc$890
- Valencia Technologies Corporation$823
- AbbVie$197
- Intuitive Surgical$165
- plus $839 from 20 others
Across 4 payments — averaging $6250.00 each. An ownership or investment interest held by the physician or an immediate family member.
- Valencia Technologies Corporation$25K
What the payments were for
- Consulting fees$7,31054%
- Travel & lodging$2,97922%
- Food & beverage$2,48818%
- Education$5754%
- Gifts$2852%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Caldera Medical, Inc | 10 | $7,826 |
| Axonics, Inc. | 28 | $2,898 |
| Astellas Pharma US Inc | 38 | $890 |
| Valencia Technologies Corporation | 1 | $823 |
| AbbVie(2 entities) | 14 | $197 |
| Intuitive Surgical | 2 | $165 |
| Boston Scientific | 2 | $134 |
| Zyla Life Sciences, Inc. | 7 | $95 |
| Medtronic | 2 | $91 |
| Coloplast | 3 | $67 |
| Millicent US Inc | 5 | $66 |
| Therapeuticsmd, Inc. | 4 | $50 |
| Amgen | 3 | $44 |
| Bayer | 2 | $41 |
| Lupin Inc. | 3 | $39 |
| Sumitomo Pharma America, Inc. | 2 | $37 |
| Hollister Incorporated | 2 | $28 |
| Teleflex LLC | 1 | $26 |
| Mayne Pharma Commercial LLC | 2 | $25 |
| ABC Home Medical Supply, Inc. | 1 | $16 |
| Pacira Pharmaceuticals Incorporated | 1 | $16 |
| Olympus America Inc. | 1 | $15 |
| AMAG Pharmaceuticals, Inc. | 1 | $14 |
| Daiichi Sankyo Inc. | 1 | $13 |
| Escala Medical Inc. | 1 | $12 |
| Pfizer | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Desara$7,677
- Axonics$2,416
- Vertessa$2,150
- Bulkamid$1,041
- eCoin Device Kit$823
- Obtryx System - Curved$109
How this compares
$13,636 in reported general payments places this provider in the 95th percentile of 1,242 obstetrics & gynecology providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 695 | $534,831 |
| GemtesaVibegron | 311 | $255,622 |
| PremarinEstrogens, Conjugated | 68 | $28,819 |
| Estradiol | 318 | $28,621 |
| Darifenacin ErDarifenacin Hydrobromide | 148 | $24,325 |
| Fesoterodine Fumarate ErFesoterodine Fumarate | 149 | $17,961 |
| Mirabegron ErMirabegron | 33 | $16,764 |
| ViberziEluxadoline | 12 | $9,493 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 275 | $6,730 |
| Trospium Chloride ErTrospium Chloride | 38 | $6,629 |
| Methenamine Hippurate | 52 | $5,988 |
| YuvafemEstradiol | 54 | $5,611 |
| Fosfomycin Tromethamine | 22 | $3,639 |
| Solifenacin Succinate | 32 | $2,750 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 97 | $1,875 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $890 | $534,831695 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $37 | $255,622311 claims |
| PfizerPremarin | $11 | $28,81968 claims |
| AbbVieViberzi | $197 | $9,49312 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,242 obstetrics & gynecology providers in New Jersey.
Other obstetrics & gynecology in Hackettstown
- Jennifer AshtonEnglewood$1.5M
- Geoffrey BowersVoorhees$228K
- Neha DeshpandePlainsboro$206K
- Paula JasionowskiVoorhees$193K
- Justin ChuraSwedesboro$179K
- Andrea VentolaFlorham Park$145K
- Aiman ShiladPaterson$100K
- Patrick CulliganMorristown$93K
- Dipak DelvadiaCherry Hill$86K
- Susan PitmanWest Orange$77K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.